Wealth Advisory Solutions’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Wealth Advisory Solutions's PFE Position: Q1 2026 in Review
Wealth Advisory Solutions increased its Pfizer (PFE) stake by 5.6% in Q1 2026, buying an estimated $35.6K and bringing the position to 25,231 shares worth $708K. The position accounts for 0.16% of the portfolio, ranked #80.
Wealth Advisory Solutions first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.73M in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wealth Advisory Solutions held 25,231 shares of Pfizer worth $708K as of Q1 2026.
- Wealth Advisory Solutions bought 1,336 Pfizer shares in Q1 2026, an estimated $35.6K.
- Pfizer made up 0.16% of Wealth Advisory Solutions's portfolio in Q1 2026, its #80 holding.
- Wealth Advisory Solutions first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
- Wealth Advisory Solutions's Pfizer position peaked at $3.73M in Q2 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wealth Advisory Solutions's 13F filing for Q1 2026, filed 22 Apr 2026.